BALCHEM CORP — Director's Dealing 2022

Sep 19, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2022-09-15

Reporting Person: Harris Theodore L (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-15	Stock Option (Right to Buy)	$	A	130000	Acquired	2032-09-15	Common Stock (130000)	Direct

Footnotes

F1: The stock options grant is structured in four tranches with increasing exercise prices as follows: (a) 25% at fair market value as of grant date of $125.71; (b) 25% at $125.71 plus 10% premium; (c) 25% at $125.71 plus 15% premium; and (d) 25% at $125.71 plus 20% premium.

F2: The stock options vest over a five-year period with: (a) 25% vesting on 9/15/2025; (b) 25% vesting on 9/15/2026; and (c) 50% vesting on 9/15/2027.